New Directions in the Biology and Therapy of Chronic Myeloid Leukemia

References

• Strife A., Clarkson B. Introduction to the Biological and Clinical Understanding of CML. Chronic Myelogenous Leukemia: Molecular Approaches to Research and Therapy, A. Deisseroth, R. Arlinghaus. Marcel Dekker, Inc., New York 1990; 90, 1
   Google Scholar
• Talpaz M., Kantarjian H., McCredie K. Hematological Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha in CML. N. Eng. J. Med 1986; 314: 1065–1069
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Clift R., Fefer A. Marrow Transplantation for the Treatment of CML. Ann. Int. Med 1986; 104: 155–163
   PubMed Web of Science ®Google Scholar
• Bacto-Babapulle F. Complete Remission After Autografting for CML. Leukemia Research 1987; 11: 1115–1117
   PubMed Web of Science ®Google Scholar
• Carroll M., Boswell H. S., Gabig T., Rapp U., Clark-Lewis I., May W. S. An Amplified IL-3 Induced c-raf Phosphorylation Accompanies the Mutant H-ras Induced Growth Acceleration by an IL-3 Dependent Myeloid Cell Line. Blood 1989; 74: 173a
   PubMedGoogle Scholar
• Bischoff J. R., Friedman P. N., Marshak D. R., Prives C., Beach D. Human P53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. USA 1990; 87: 4766–4770
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffen J., Warnes H. P., Huang C. M., Livingston D. M. The Product of the Retinoblastoma Susceptibility Gene has the Properties of a Cell Cycle Regulatory Element. Cell 1989; 58: 1085–95
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy C. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• Kessler D. S., Levy D. E., Darnell J. E., Jr. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Science USA 1988; 85: 8521–8525
   PubMed Web of Science ®Google Scholar
• Wedrychowski A., Seong D., Paslidis N., Johnson E., Howard O. M. Z., Sims S., Talpaz M., Kantarjian J. H., Hester J., Turpin J., Lopez-Berestein G., Gutterman J., Freireich E., Deisseroth A. Characterization of nuclear proteins which bind to interferon-inducible transcriptional enhancers in hematopoietic cells. J. Biol. Chem 1990; 265: 21433–21440
   PubMed Web of Science ®Google Scholar
• Upadhayaya G., Guba S. C., Sih S. A., Feinberg A. P., Tolporz M., Kavlayian H., Deisseroth A., Emerson S. Interferon alpha restores the deficient expression of the globohesion *** LFA 3 by CML progeniterales. ICI 1991, in press
   Google Scholar
• Daley G., Baltimore D. Transformation of an Interleukin 3-Dependent Hematopoietic Cell Line by the CML-Specific P210bcr-abl protein. Proc. Natl. Acad. Sci. USA 1988; 85: 9312–9316
   PubMed Web of Science ®Google Scholar
• Hariharan I. K., Adams J. M., Cary S. Bcr-abl Oncogene Renders Myeloid Cell Line Factor Independent: Potential Autocrine Mechanism in CML. Oncogene Research 1988; 3: 387–399
   PubMedGoogle Scholar
• Talpaz M. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann. Int. Med 1991; 114: 532–538, 1991.
   PubMed Web of Science ®Google Scholar
• Howard O. M. Z., Talpaz M., Kantarjian H., Seong D., Wedrychowski A., Paslidis N., Hester J., Cork A., Turpin J., Lopez-Berestein G., Trujillo J., Guterman J., Freireich E., Deisseroth A. Interferon Affects Nuclear Proteins in Cells of Clinically Sensitive CML Patients. Blood 1990; 75: 1117–1130
   Google Scholar
• Seong D., Sims S., Johnson E., Howard O. M. Z., Reiter B., Hester J., Talpaz M., Kantarjian H., Deisseroth A. A Phosphatase Activity Present in Peripheral Blood Myeloid Cells of CML Patients but not Normal Individuals Alters Nuclear Protein Binding to Transcriptional Enhancers of Interferon-Inducible Genes. J. Clin. Invest 1990; 86: 1664–1670
   PubMed Web of Science ®Google Scholar
• Seong D., Sims S., Johnson E., Lyding J., Lopez A., Garovoy M., Talpaz M., Lopez-Berestein G., Reading C., Deisseroth A. Activation of Class I HLA Expression is Mediated by TNF-Alpha and Gamma-Interferon Through Protein Kinase C-Dependent Pathway in CML Cell Lines. Brit. J. Haematol 1991; 78: 359–367, 1991.
   PubMed Web of Science ®Google Scholar
• Wedrychowski A., Henzel W., Huston J., Paslidis N., Ellerson D., Seong D., Howard O. M. Z., Deisseroth A. Identification of Proteins Binding to Interferon-Inducible Transcriptional Enhancers in Hematopoietic Cells. 1991, preparation
   Google Scholar
• Gao P. Q., Sims S., Deisseroth A. Functional Characterization of the Proteins Which Bind to the Interferon-Inducible Transcriptional Enhancers. 1991, Preparation
   Google Scholar
• Johnson E., Deisseroth A. Analysis of Proteins Which Alters Interferon Sensitivity. 1991, preparation
   Google Scholar
• Kantarjian H., Talpaz M., LeMaistre C. F., Spinolo J., Spitzer G., Yau J., Dicke K., Yagannath S., Dassuoth A. Structure Combination Chemotherapy and Autotegous Bone Marrow Transplantation Leads to the Reappearance of Philadelphia Chromosome Negative Cells in CML. Cancer 1991; 67: 2959–2965
   PubMed Web of Science ®Google Scholar
• Kantarjian H., Talpaz M., Gutterman J., Kantoyiannis D., Keating M., Estey E., O'Brien S., Rios M., Beran M., Deisseroth A. Treatment of CML in Accelerated and Blastic Phases with Daunorubicin, Cytosine Arabinoside, and GMCSF. 1991, Submitted
   Google Scholar
• Deisseroth A. Integration of Molecular Biology and Genetics with Biological and Chemotherapeutic Approaches to the Management of Chronic Myelogenous Leukemia (CML). 4th International Management Symposium in ABMT, K. Dicke, J. Armitage, M. J. Evinger-Hodges, 1991; 229–237
   Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 288: 342–345
   Web of Science ®Google Scholar
• Yuan T. Y., Chen, Hanchun, Herst C. V., Guo J. Q., Reading C., Liu J., Arlinghaus R., Deisseroth A. In Vitro Antisense Oligonucleotides Homologous to BCR-ABL mRNA Inhibit Growth of Philadelphia Chromosome Positive Cell Lines. 1991, Preparation
   Google Scholar
• Caracciolo D., Valtrero M., Venturelli D., Pesche C., Gewirtz A., Calabretta B. Lineage Specific Requirement of c-abl Function in Normal Myeloid Cells. Science 1989; 245: 1107–1110
   PubMed Web of Science ®Google Scholar
• Cornetta K., Moen R., Culver K., Morgan R., McLachlin J., Sturm S., Sclegue J., Lonshon W., Blaise M., Anderson W. F. Human Gene Therapy 1990; 1: 15–30
   PubMed Web of Science ®Google Scholar